CAR T across hematological malignancies: trials to watch

Axicabtagene ciloleucel, an anti-CD19 CAR T-cell product, has shown impressive efficacy in diffuse large B-cell lymphoma already. In this video, recorded at the 2018 Society of Hematologic Oncology (S... Author: VJHemOnc Added: 09/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts